Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002614361 | SCV002966599 | pathogenic | Nemaline myopathy 2 | 2022-02-10 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with NEB-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Ser6654Alafs*27) in the NEB gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NEB are known to be pathogenic (PMID: 25205138). |
Fulgent Genetics, |
RCV005019291 | SCV005650418 | likely pathogenic | Nemaline myopathy 2; Arthrogryposis multiplex congenita 6 | 2024-05-23 | criteria provided, single submitter | clinical testing |